GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®
EPIDYOLEX was approved in the EU after four randomized and controlled Phase 3 trials had been conducted
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• October 2, 2019
Load More Stories